Skip to main content

Table 2 Differences in the expression levels of various proteins in EPA-treated PC3 cells relative to the control (related to Fig. 5)

From: Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells

  1. 1. Differences relative to the control are shown as ± ± ± ± > 20%
  2. 2. Differences relative to the control are shown as ± ± ± > 10%
  3. 3. Differences relative to the control are shown as ± ± > 5%
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X